Czechia, Feb. 26 -- Czechia based Gilead Sciences s.r.o. has secured contract from Ustredni vojenska nemocnice - Vojenska fakultni nemocnice Praha for Antivirals for systemic use - Sofosbuvir, Velpatasvir, Voxilaprevir. The value of the contract is worth 904109472 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....